Novel mechanism of signaling by CD28

Immunol Lett. 2010 Mar 10;129(1):1-6. doi: 10.1016/j.imlet.2010.01.007. Epub 2010 Feb 1.

Abstract

Ligation of both the T cell receptor (TCR) and the CD28 receptor is required for full T cell activation to occur. Engagement of the TCR in primary T cells is followed by rapid cAMP production in lipid rafts and activation of the cAMP-protein kinase A (PKA)-Csk pathway inhibiting proximal T cell signaling. However, CD28 stimulation leads to recruitment of a beta-arrestin/phosphodiesterase-4 (PDE4) complex to rafts, resulting in down-regulation of cAMP levels. Thus, the activities of both PKA and PDE4 seem to be important for regulation of TCR-induced signaling and T cell function. This review will focus on the novel mechanism whereby CD28 through PI3K regulates recruitment of a PKB/beta-arrestin/PDE4 complex thereby allowing a complete T cell activation to proceed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arrestins / metabolism
  • CD28 Antigens / immunology
  • CD28 Antigens / metabolism*
  • Cyclic Nucleotide Phosphodiesterases, Type 4 / metabolism
  • Humans
  • Lymphocyte Activation
  • Membrane Microdomains / immunology*
  • Multiprotein Complexes / immunology*
  • Protein Kinases / metabolism
  • Receptors, Antigen, T-Cell / metabolism
  • Signal Transduction / immunology*
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / pathology
  • beta-Arrestins

Substances

  • Arrestins
  • CD28 Antigens
  • Multiprotein Complexes
  • Receptors, Antigen, T-Cell
  • beta-Arrestins
  • Protein Kinases
  • Cyclic Nucleotide Phosphodiesterases, Type 4